Sensitive and specific serodiagnosis of lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE

Journal of Clinical Microbiology

Volumn 37, Issue 12, 1999, Pages 3990-3996

  Ting Liang, Fang ^a   Steere, Allen C ^b   Marques, Adriana R ^c   Johnson, Barbara J B ^d   Miller, James N ^e   Philipp, Mario T ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MEMBRANE ANTIGEN; MEMBRANE ANTIGEN VLSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY TITER; ARTICLE; BORRELIA BURGDORFERI; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; LYME DISEASE; MONKEY; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; SERODIAGNOSIS; SYNDROME DELINEATION;

ANIMALIA; BORRELIA; BORRELIA BURGDORFERI;

EID: 0344286138     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.12.3990-3996.1999     Document Type: Article

References (42)

1. Bakken, L. L., S. M. Callister, P. J. Wand, and R. F. Schell. 1997. Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists proficiency testing program. J. Clin. Microbiol. 35:537-543.
2. Barbour, A. G., S. L. Tessier, and S. F. Hayes. 1984. Variation in a major surface protein of Lyme disease spirochetes. Infect. Immun. 45:94-100.
3. Barbour, A. G., S. F. Hayes, R. A. Heiland, M. E. Schrumpf, and S. F. Tessler. 1986. A Borrelia genus-specific monoclonal antibody binds to a flagellar epitope. Infect. Immun. 52:549-554.
4. Barony, G., and R. B. Merrifield. 1980. The peptides: analysis, synthesis, & biology, p. 3-285. Academic Press, New York, N.Y.
5. Burkot, T. R., M. E. Schriefer, and S. A. Larsen. 1997. Cross-reactivity to Borrelia burgdorferi proteins in serum samples from residents of a tropical country nonendemic for Lyme disease. J. Infect. Dis. 175:466-469.
6. Centers for Disease Control and Prevention. 1997. Case definition for infectious conditions under public health surveillance. Morbid. Mortal. Weekly Rep. 46:20-21.
7. Centers for Disease Control and Prevention. 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morbid. Mortal. Weekly Rep. 44:590-591.
8. Centers for Disease Control and Prevention. 1997. Lyme disease - United States, 1996. Morbid. Mortal. Weekly Rep. 46:531-535.
9. Centers for Disease Control and Prevention. 1998. Guidelines for treatment of sexually transmitted diseases. Morbid. Mortal. Weekly Rep. 47:33.
10. Dressler, F., J. A. Whalen, B. N. Reinhardt, and A. C. Steere. 1993. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 167:392-400.
11. Engstrom, S. M., E. Snoop, and R. C. Johnson. 1995. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 33:419-427.
12. Fawcett, P. T., K. M. Gibney, C. D. Rose, S. B. Dubbs, and R. A. Doughty. 1992. Frequency and specificity of antibodies that crossreact with Borrelia burgdorferi antigens. J. Rheumatol. 19:582-587.
13. Fawcett, P. T., K. M. Gibney, C. D. Rose, J. D. Klein, and R. A. Doughty. 1991. Adsorption with a soluble E. coli antigen fraction improves the specificity of ELISA tests for Lyme disease. J. Rheumatol. 18:705-708.
14. Fawcett, P. T., C. D. Rose, and K. M. Gibney. 1995. Comparative evaluation of adsorption with E. coli on ELISA tests for Lyme borreliosis. J. Rheumatol. 22:684-688.
15. Feng, S., E. Hodzic, B. Stevenson, and S. W. Barthold. 1998. Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice. Infect. Immun. 46:2827-2835.
16. Hansen, K., J. M. Bangsborg, H. Fjordvang, N. S. Pederson, and P. Hindersson. 1988. Immunochemical characterization of and isolation of the gene for a Borrelia burgdorferi immunodominant 60-kilodalton antigen component to a wide range of bacteria. Infect. Immun. 56:2047-2053.
17. Indest, K. J., R. Ramamoorthy, M. Sole, R. D. Gilmore, B. J. B. Johnson, and M. T. Philipp. 1997. Cell-density-dependent expression of Borrelia burgdorferi lipoproteins in vitro. Infect. Immun. 65:1165-1171.
18. Liang, F. T., A. L. Alvarez, Y. Gu, J. M. Nowling, R. Ramamoorthy, and M. T. Philipp. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. J. Immunol., in press.
19. Liang, F. T., and M. T. Phllipp. 1999. Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi. Infect. Immun. 67:6702-6706.
20. Luft, B. J., P. D. Gorevic, W. Jiang, P. Munoz, and R. J. Dattwyler. 1991. Immunologic and structural characterization of the dominant 66- to 73-kDa antigens of Borrelia burgdorferi. J. Immunol. 146:2776-2783.
21. Ma, B., B. Christen, D. Leung, and C. Vigo-Pelfrey. 1992. Serodiagnosis of Lyme borreliosis by Western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. J. Clin. Microbiol. 30:370-376.
22. Magnarelli, L. A., J. F. Anderson, and R. C. Johnson. 1987. Cross-reactivity in serological tests for Lyme disease and other spirochetal infection. J. Infect. Dis. 156:183-188.
23. Margolis, N., and P. A. Rosa. 1993. Regulation of expression of major surface proteins in Borrelia burgdorferi. Infect. Immun. 61:2207-2210.
24. Nadelman, R. B., and G. P. Wormser. 1998. Lyme borreliosis. Lancet 352: 557-564.
25. Norris, S. J., C. J. Carter, J. K. Howell, and A. G. Barnour. 1992. Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect. Immun. 60:4662-4672.
26. Philipp, M. T., Y. Lobet, R. P. Bohm, Jr., M. D. Conway, V. A. Dennis, P. Desmons, Y. Gu, P. Hauser, R. C. Lowrie, Jr., and E. D. Roberts. 1996. Safety and immunogenicity of recombinant outer surface protein a (OspA) vaccine formulations in the rhesus monkey. J. Spirochetal Tickborne Dis. 3:67-79.
27. Philipp, M. T., M. K. Aydintug, R. P. Bohm, Jr., F. B. Cogswell, V. A. Dennis, H. N. Lanners, R. C. Lowrie, Jr., E. D. Roberts, M. D. Conway, M. Karacorlu, G. A. Peyman, D. J. Gubler, B. J. B. Johnson, J. Piesman, and Y. Gu. 1993. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect. Immun. 61:3047-3059.
28. Philipp, M. T., Y. Lobet, R. P. Bohm, Jr., E. D. Roberts, V. A. Dennis, Y. Gu, R. C. Lowrie, Jr., P. Desmons, P. H. Duray, J. England, P. Hauser, J. Piesman, and K. Xu. 1997. The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey. Vaccine 15:1872-1887.
29. Ramamoorthy, R., and M. T. Philipp. 1998. Differential expression of Borrelia burgdorferi proteins during growth in vitro. Infect. Immun. 66:5119-5124.
30. Sigal, L. H. 1997. Pitfalls in the diagnosis and management of Lyme disease. Arthritis Rheum. 41:195-204.
31. Sigal, L. H., J. M. Zahradnik, P. Lavin, S. J. Patella, G. Bryant, R. Haselby, E. Hilton, M. Kunkel, D. Adler-Klein, T. Doherty, J. Evans, P. J. Molloy, A. L. Seidner, J. R. Sabetta, H. J. Simon, M. S. Klempner, J. Mays, D. Marks, and S. E. Malawista. 1998. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. N. Engl. J. Med. 339:216-222.
32. Simpson, W. J., M. E. Schrumpf, and T. G. Schwan. 1990. Reactivity of human Lyme borreliosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi. J. Clin. Microbiol. 28:1329-1337.
33. Steere, A. C. 1989. Lyme disease. N. Engl. J. Med. 321:586-596.
34. Steere, A. C., E. Taylor, G. L. McHugh, and E. L. Logigian. 1993. The overdiagnosis of Lyme disease. JAMA 269:1812-1816.
35. Steere, A. C., R. E. Levin, P. J. Molloy, R. A. Kalish, J. H. Abraham 3rd, N. Y. Liu, and C. H. Schmid. 1994. Treatment of Lyme arthritis. Arthritis Rheum. 37:878-888.
36. Steere, A. C., V. K. Sikand, F. Meurice, D. L. Parenti, E. Fikrig, R. T. Schoen, J. Nowakowski, C. H. Schmid, S. Laukamp, C. Buscarino, and D. S. Krause. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N. Engl. J. Med. 339:209-215.
37. Tugwell, P., D. T. Dennis, A. Weinstein, G. Wells, B. Shea, G. Nichol, R. Hayward, R. Lightfoot, P. Baker, and A. C. Steere. 1997. Clinical guideline, part 2: laboratory evaluation in the diagnosis of Lyme disease. Ann. Intern. Med. 127:1109-1123.
38. van Hoecke, C., M. Comberbach, D. de Grave, P. Desmons, D. Fu, P. Hauser, E. Lebacq, Y. Lobet, and P. Voet. 1996. Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) Lyme vaccines in healthy adults. Vaccine 14:1620-1626.
39. Wang, I. N., D. E. Dykhuizen, W. Qiu, J. J. Dunn, E. M. Bosler, and B. J. Luft, 1999. Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 151:15-30.
40. Wilske, B., V. Preac-Mursic, S. Jauris, A. Hofmann, I. Pradel, E. Soutschek, E. Schwab, G. Will, and G. Wanner. 1993. Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi. Infect. Immun. 61:2182-2191.
41. Wormser, G. P., H. W. Horowitz, I. S. Dumler, I. Schwartz, and N. E. Agüero-Rosenfeld. 1996. False-positive Lyme disease serology in human granulocytic ehrlichiosis. Lancet 347:981.
42. Zhang, J. R., J. M. Hardham, A. G. Barbour, and S. J. Norris. 1997. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275-285.